Journal
JOURNAL OF DERMATOLOGICAL SCIENCE
Volume 99, Issue 3, Pages 146-151Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.jdermsci.2020.06.001
Keywords
RIPK1; Inflammation; Psoriasis; Systemic lupus erythematosus; Melanoma; Skin disease
Categories
Funding
- National Natural Science Foundation of China [81974479]
Ask authors/readers for more resources
Skin diseases bring great psychological and physical impacts on patients, however, a considerable number of skin diseases still lack effective treatments, such as psoriasis, systemic lupus erythematosus, melanoma and so on. Receptor-interacting serine threonine kinase 1 (RIPK1) plays an important role in cell death, especially necroptosis, associated with inflammation and tumor. As many molecules modulate the ubiquitination of RIPK1, disruption of this checkpoint can lead to skin diseases, which can be ameliorated by RIPK1 inhibitors. This review will focus on the molecular mechanism of RIPK1 activation in inflammation as well as the current knowledges on the contribution of RIPK1 in skin diseases. (C) 2020 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available